KALV — Kalvista Pharmaceuticals Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy
U.S. STOCKS ON THE MOVE-ICON, Old Dominion, Energy companies
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Phillips 66, Cognizant, AbbVie
KalVista jumps as Italy’s Chiesi to acquire it for $1.9 bln
Italian pharma group Chiesi to buy US peer KalVista for $1.9 billion (updated)
Italian drugmaker Chiesi to buy KalVista for $1.9 billion
NASDAQ RESUMED AT 07:35 AM
Italian pharma group Chiesi to buy US peer KalVista for $1.9 billion
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Brief: Kalvista Pharmaceuticals To Report Eight Months Fiscal Year 2025 Financial Results And Provide Corporate Update On March 25, 2026
Brief: Kalvista Pharmaceuticals Announces Inclusion Of Ekterly® As A First-Line Therapy
Brief: Kalvista Pharma Provides Update On Strong EKTERLY Launch
KalVista Pharma falls after $125 mln convertible debt sale
Brief: Kalvista Pharmaceuticals Announces Proposed Offering Of $110.0 Million Of Convertible Senior Notes
KalVista Pharma falls after announcing $110 mln convertible debt offering